Schedule 13G ownership disclosure

ROIVANT SCIENCES LTD SHS

Common Shares, $0.0000000341740141 par value per share · CUSIP: G76279101

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • VIKING GLOBAL INVESTORS LP

    Shares: 46,013,752 · Class: 6.4%

  • VIKING GLOBAL PERFORMANCE LLC

    Shares: 24,547,654 · Class: 3.4%

  • Viking Global Equities II LP

    Shares: 490,954 · Class: 0.1%

  • Viking Global Equities Master Ltd.

    Shares: 24,056,700 · Class: 3.4%

  • Viking Long Fund GP LLC

    Shares: 8,959,894 · Class: 1.3%

  • Viking Long Fund Master Ltd.

    Shares: 8,959,894 · Class: 1.3%

  • Viking Global Opportunities Parent GP LLC

    Shares: 12,506,204 · Class: 1.8%

  • Viking Global Opportunities GP LLC

    Shares: 12,506,204 · Class: 1.8%

  • Viking Global Opportunities Portfolio GP LLC

    Shares: 12,506,204 · Class: 1.8%

  • Viking Global Opportunities Illiquid Investments Sub-Master LP

    Shares: 12,506,204 · Class: 1.8%

  • HALVORSEN OLE ANDREAS

    Shares: 46,013,752 · Class: 6.4%

  • Ott David C.

    Shares: 46,013,752 · Class: 6.4%

  • Shabet Rose Sharon

    Shares: 46,013,752 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905148-25-001762
Form type
SCHEDULE 13G/A
Filer
Roivant Sciences Ltd.
CIK
CIK 1635088
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub